$3.06
+0.17(5.69%)
Mkt Cap $195M
$1.10
$3.43
52-Week Range
At a Glance
AI-generatedMacroGenics, Inc.
Revenue breakdown: Revenues From License Agreements (47.2%), Revenue From Collaborative Agreements (29.3%), Contract Manufacturing (9.3%).
8-K
MacroGenics, Inc. announced financial and operating results as of and for the year ended December 31, 2025, via press release dated March 9, 2026. The filing includes Exhibit 99.1 detailing these results and Exhibit 104 for cover page interactive data.$195M
Market Cap
$150M
Revenue
-$75M
Net Income
Employees341
Fundamentals
How The Business Makes Money
Revenue by Segment
Revenues From License Agreements47.2%($383M)
Revenue From Collaborative Agreements29.3%($238M)
Contract Manufacturing9.3%($76M)
Revenues From CMO Agreements Member7.1%($58M)
Product4.2%($34M)
Manufacturing Services1.6%($13M)
Revenue From Royality Agreements Member1.3%($11M)
Activity
What Changed Recently
Analyst View
Company Profile
CIK0001125345
ISINUS5560991094
CUSIP556099109
Phone301 251 5172
Address9704 Medical Center Drive, Rockville, MD, 20850, US
SEC EDGAR